Franklin R. Schneier, MD
Dr. Franklin Schneier is a Special Lecturer at Columbia University College of Physicians and Surgeons and Research Psychiatrist in the Anxiety Disorders Clinic at New York State Psychiatric Institute. Dr. Schneier is a graduate of Yale College and Cornell University Medical College, and he completed his residency in psychiatry at Mt. Sinai Medical Center. He came to the Anxiety Disorders Clinic in 1987 as a research fellow, later serving as associate director of the clinic and currently as a research psychiatrist. He is a member of the Scientific Advisory Board of the Anxiety Disorders Association of America.
Dr. Schneier's research has focused on the diagnosis, treatment, and pathophysiology of social anxiety disorder, other anxiety disorders, and depression. He has been the recipient of Federal funding to conduct clinical trials establishing the efficacy of medications and combined medication-cognitive-behavioral treatments for social anxiety disorder and PTSD. He is also trained in cognitive-behavioral therapy. Dr. Schneier has also been funded by NIMH to use PET and fMRI imaging techniques to study social anxiety disorder and depression. He is author of more than 150 scholarly publications and a book for general audiences, The Hidden Face of Shyness.
Dr. Schneier also maintains a private practice in general psychiatry, including diagnostic assessment and consultations, psychopharmacology and cognitive-behavioral therapy. He combines a focus on evidence-based treatment with recognition of the need for a creative and individualized approach to the unique aspects of each person.
My research interests include the integration of pharmacological and cognitive-behavioral approaches to treatment of social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder, and the application of PET and fMRI to understanding brain function in these conditions.
My current research includes a randomized clinical trial of medication treatment for PTSD, a randomized clinical trial of medication for separation anxiety disorder, a PET neuroimaging study of motivation in depression, and a study of the function of neural circuits that mediate fear learning, prepulse inhibition, attention to threat, and capacity to delay reward across several conditions: social anxiety disorder, obsessive-compulsive disorder, and anorexia nervosa.